Feds And Marijuana Opponents Agree On Briefing Schedule In Lawsuit Challenging Trump’s Reclassification Move
The Department of Justice and groups that oppose the Trump administration’s marijuana rescheduling move have agreed on what they believe the schedule should be in an ongoing lawsuit that seeks to block to reform. On Friday, federal officials who are defending the cannabis reform and the challengers behind the litigation filed a joint brief before […]
DEA Opens New Schedule III Registration Portal for Medical Cannabis Businesses
The DEA has opened a new registration process for state-licensed medical cannabis manufacturers, distributors and analytical laboratories seeking to operate under Schedule III. The move brings qualifying medical cannabis businesses into a federal controlled-substances framework while potentially offering major tax advantages by ending the Section 280E deduction ban for those businesses. Schedule III Is Coming […]
The Record That Decides Whether Weed Leaves Schedule I Just Needed 294 Corrections. A Few Reversed What Witnesses Said.
Part V of our coverage of the federal rescheduling case. Part IV covered the post-hearing briefs. The Corrections That Changed the Meaning Why It Matters, and How Much 294 fixes across 2,533 pages is roughly one every nine pages, and most are spelling and speaker names. A handful did something else: they changed the meaning, […]
Federal Appeals Court Sets Schedule For Lawsuit Challenging Medicare Hemp Coverage Program
A federal appeals court has laid out the schedule for a lawsuit brought by a coalition of anti-marijuana groups and a cannabis-focused biopharmaceutical corporation that are challenging the Trump administration’s initiative to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. In May, Judge Trevor N. McFadden dismissed the challenge […]